Athanasios T.
- Country
- Germany
- Department
- 40740:Dermatology
Research Overview
- Phase 1b Multicenter Double-Blind Placebo-Controlled Study on Safety, Tolerability, and Efficacy of si-544 in Psoriasis Vulgaris and Psoriatic Arthritis
- B7981040 - A PHASE 3 RANDOMIZED, DOUBLE-BLIND, 52-WEEK PLACEBOCONTROLLED, MULTI-CENTER STUDY INVESTIGATING THE EFFICACY, SAFETY, AND TOLERABILITY OF RITLECITINIB IN ADULT AND ADOLESCENT PARTICIPANTS WITH NONSEGMENTAL VITILIGO
- A phase 2B, multicenter, randomized, double-blind, placebo-controlled, dose-finding, efficacy and safety study of HRO350 in subjects with mild-to-moderate psoriasis (the ‘HeROPA’ study)
Data & Insights
Has run more than one trial at 672 of 1057 partner sites.
Specializations
Inflammatory Skin Conditions
Specializes in investigating therapeutic approaches for chronic inflammatory dermatological conditions, with particular emphasis on atopic dermatitis and plaque psoriasis.
- Moderate to severe atopic dermatitis management
- Plaque psoriasis treatment innovations
- Pediatric dermatology applications
Evaluates novel therapeutic agents and their long-term safety profiles in chronic skin conditions.
Autoimmune Dermatology
Focuses on advancing treatment options for autoimmune skin disorders, particularly cutaneous lupus erythematosus and chronic spontaneous urticaria.
- Subacute and chronic cutaneous lupus
- Urticaria management strategies
- Alopecia areata interventions
Investigates targeted therapies for complex autoimmune dermatological manifestations.
Specialized Dermatological Conditions
Conducts research on distinct dermatological disorders including hidradenitis suppurativa and prurigo nodularis.
- Hidradenitis suppurativa treatment approaches
- Prurigo nodularis management
- Scabies therapeutic interventions
Explores innovative treatment modalities for challenging dermatological conditions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.